| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12 |
| filingDate |
2021-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba03dde2aa0555579872e10b51f744d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d313623b442812f4d54ae084f3b2cb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12d76588ea5ed5de0f03e00264447fc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd7e634aa3ba6b6227447e5f222bb02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d1b3914fde340b9102358faed705f93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f289908fbe8974cecaf8371291a0f15f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c42fd05e12273a199f952b6426dc6eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c156c20b2f5ea3f6e4c0d5e478e2a0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed77dcb217250e4f1b7206eb6ee45146 |
| publicationDate |
2022-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022073523-A1 |
| titleOfInvention |
Process for preparing beta 3 agonists and intermediates |
| abstract |
The application is directed to efficient and economical processes as described in more detail below for the preparation of the beta 3 agonists of the formula of I-7 and intermediate compounds that can be used for making these agonists. The present disclosure relates to a process for making beta-3 agonists and intermediates using ketoreductase (KRED) biocatalyst enzymes and methods of using the biocatalysts. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11708371-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11767292-B2 |
| priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |